Shopping Cart 0
Cart Subtotal
USD 0

Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Sareum Holdings Plc (SAR)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, VEGFR-3 (FLT4) kinase, fatty acid synthase (FASN), tyrosine kinase 2 (TYK2), ALK kinase, FLT3 and microtubule binding agents. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Pampisford, Cambridge, the UK.

Sareum Holdings Plc Key Recent Developments

Nov 13,2018: Sareum Holdings: Michael Owen, PhD and Clive Birch appointed as non-executive directors

Oct 01,2018: Sareum Holdings announce final results for the year ended 30 June 2018

Mar 13,2018: Sareum Holdings: Half-yearly Results for the Six Months Ended 31 December 2017

Oct 19,2017: Sareum Holdings: Final Results for the year ended 30 June 2017

Feb 20,2017: Sareum Holdings Announces Half-Yearly Results For The Six Months Ended 31 December 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Sareum Holdings Plc-Key Facts 5

Sareum Holdings Plc-Key Employees 6

Sareum Holdings Plc-Key Employee Biographies 7

Sareum Holdings Plc-Major Products and Services 8

Sareum Holdings Plc-History 9

Sareum Holdings Plc-Company Statement 12

Sareum Holdings Plc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Sareum Holdings Plc-Business Description 16

Sareum Holdings Plc-Corporate Strategy 17

Sareum Holdings Plc-SWOT Analysis 18

SWOT Analysis-Overview 18

Sareum Holdings Plc-Strengths 18

Sareum Holdings Plc-Weaknesses 19

Sareum Holdings Plc-Opportunities 20

Sareum Holdings Plc-Threats 21

Sareum Holdings Plc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Sareum Holdings Plc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Nov 13, 2018: Sareum Holdings: Michael Owen, PhD and Clive Birch appointed as non-executive directors 32

Oct 01, 2018: Sareum Holdings announce final results for the year ended 30 June 2018 33

Mar 13, 2018: Sareum Holdings: Half-yearly Results for the Six Months Ended 31 December 2017 39

Oct 19, 2017: Sareum Holdings: Final Results for the year ended 30 June 2017 44

Feb 20, 2017: Sareum Holdings Announces Half-Yearly Results For The Six Months Ended 31 December 2016 45

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Sareum Holdings Plc, Performance Chart (2014-2018) 26

Sareum Holdings Plc, Ratio Charts 28

Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Sareum Holdings Plc, Key Facts 5

Sareum Holdings Plc, Key Employees 6

Sareum Holdings Plc, Key Employee Biographies 7

Sareum Holdings Plc, Major Products and Services 8

Sareum Holdings Plc, History 9

Sareum Holdings Plc, Subsidiaries 14

Sareum Holdings Plc, Key Competitors 22

Sareum Holdings Plc, Ratios based on current share price 23

Sareum Holdings Plc, Annual Ratios 24

Sareum Holdings Plc, Annual Ratios (Cont...1) 25

Sareum Holdings Plc, Interim Ratios 27

Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Sareum Holdings Plc, Recent Deals Summary 31

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sareum Holdings Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Ultimate Finance Holdings Limited

Proximagen Group Ltd

Genus Plc

IXICO Plc

Cyprotex Ltd

Scancell Holdings Plc

Physiomics Plc

ValiRx Plc

Synairgen Plc